Jaguar Health, Inc. (NASDAQ:JAGX)

BRIEF

published on 05/28/2024 at 14:35, 5 months 26 days ago

Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea

Napo Pharmaceuticals Crofelemer Jaguar Health Study Results Functional Diarrhea
PRESS RELEASE

published on 05/28/2024 at 14:30, 5 months 26 days ago

Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency

Napo Pharmaceuticals Crofelemer Functional Diarrhea Plant-based Prescription Drug Abdominal Pain
BRIEF

published on 05/23/2024 at 14:35, 6 months ago

Jaguar Health to Showcase Gelclair for Oral Mucositis at ASCO Annual Meeting

Jaguar Health Gelclair Oral Mucositis Cancer Supportive Care ASCO Annual Meeting
PRESS RELEASE

published on 05/23/2024 at 14:30, 6 months ago

Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
Jaguar Health, Inc. announces commercial launch at ASCO Annual Meeting for Gelclair, FDA-approved oral mucositis product. Focus on cancer supportive care with phase 3 OnTarget trial results impending

Jaguar Health Phase 3 Trial Gelclair Oral Mucositis ASCO Annual Meeting
BRIEF

published on 05/17/2024 at 22:20, 6 months 6 days ago

Jaguar Health, Inc. Announces Reverse Stock Split

Jaguar Health Inc Reverse Stock Split Nasdaq Compliance Institutional Investors Stock Adjustment
PRESS RELEASE

published on 05/17/2024 at 22:15, 6 months 6 days ago

Jaguar Health, Inc. Announces Reverse Stock Split
Jaguar Health announces reverse split approval at Special Meeting of Stockholders to boost Nasdaq compliance. Stock trading on split-adjusted basis from May 23, 2024. Details in SEC filing

Stockholders Meeting Jaguar Health Nasdaq Compliance Reverse Split SEC Filing
BRIEF

published on 05/14/2024 at 14:05, 6 months 9 days ago

Jaguar Health Reports First Quarter 2024 Financial Results

Financial Results Crofelemer Jaguar Health Q1 2024 Gelclair
PRESS RELEASE

published on 05/14/2024 at 14:00, 6 months 9 days ago

Jaguar Health Reports First Quarter 2024 Financial Results
Jaguar Health, Inc. reports Q1 2024 financial results, with revenue increasing 20% over Q1 2023. Key updates include OnTarget trial progress and Gelclair® commercial launch plans

Financial Results Jaguar Health Q1 2024 OnTarget Trial Gelclair
BRIEF

published on 05/13/2024 at 18:40, 6 months 10 days ago

Jaguar Health, Inc. Announces Q1 2024 Webcast to Discuss Financials and Corporate Updates

Earnings Report Jaguar Health Q1 2024 Financial Webcast Corporate Updates
PRESS RELEASE

published on 05/13/2024 at 18:35, 6 months 10 days ago

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
Jaguar Health, Inc. to conduct investor webcast on May 14, 2024 at 8:30 a.m. Eastern to review first-quarter 2024 financials and provide corporate updates. Company plans to file its Earnings Report on the same day

Investor Webcast Form 10-Q Jaguar Health Inc. Corporate Updates First-quarter Financials

Published on 11/22/2024 at 23:55, 1 day 6 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 6 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 7 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 7 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 7 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 11 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 12 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 12 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 13 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 14 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 1 day 15 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 23 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News